A new approach to de novo minimal change disease in pregnancy

Nephrology (Carlton). 2021 Aug;26(8):692-693. doi: 10.1111/nep.13871. Epub 2021 Mar 16.

Authors

Sarah Gleeson¹, Filipa Cardoso¹, Liz Lightstone^{1

2}, Philip Webster^{1

2}, Kerry Munro³, Thomas Cairns¹

Affiliations

¹ Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, UK.
² Centre for Inflammatory Disease, Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, UK.
³ Queen Charlotte and Chelsea Hospital, Imperial College Healthcare NHS Trust, London, UK.

PMID: 33728704
DOI: 10.1111/nep.13871

No abstract available

Publication types

Letter

MeSH terms

Female
Humans
Immunosuppressive Agents / therapeutic use*
Nephrosis, Lipoid / drug therapy*
Pregnancy
Pregnancy Complications / drug therapy*
Tacrolimus / therapeutic use*
Young Adult

Substances

Immunosuppressive Agents
Tacrolimus